Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exploring Bacteria-Destroying Proteins for More Efficient Antibiotics

Published: Wednesday, October 09, 2013
Last Updated: Wednesday, October 09, 2013
Bookmark and Share
The studies offer a potential move towards a new generation of antibiotic treatment that is less prone to bacterial resistance.

A research team, led by the National Physical Laboratory (NPL), has carried out studies into how protein fragments found in our bodies destroy harmful bacteria .

The protein fragments, known as antimicrobial peptides, have fought bacteria in the human body for thousands of years by identifying and disrupting the structure of the bacterial membrane. But little is still known about the precise mechanisms they use to carry out this process. The NPL-led team conducted two separate studies to better understand the process and help assess the feasibility of using human antimicrobial peptides as the basis of new treatments.

The first study used de novo protein design and nanoscale imaging techniques, Atomic Force Microscopy and high resolution Mass Spectrometry, together with computer simulations. This combination, never used before for this application, allowed the scientists to study how the peptides destroy the bacteria on a molecular level.

The research, reported in PNAS, revealed that the peptides form nanoscale pores in the bacterial membranes, which subsequently expand until the membrane completely disintegrates. In targeting the membrane, a heterogeneous structure composed predominantly of proteins and lipids, it is thought that the peptides reduce the likelihood that bacteria will develop resistance. This is because many genes would need to mutate simultaneously in order to do so – a very unlikely scenario. 

However, before they are considered for medical use, it is important that scientists understand the likelihood of bacteria becoming resistant to the peptides. A second NPL-led study looked to do just that, using a combination of measurements, imaging and molecular dynamics simulations. It explored whether and how bacteria could develop resistance to these antibiotic peptides as they have to conventional antibiotics like methicillin.  

The findings, reported in the Journal of Biological Chemistry, suggest that antagonistic peptide chains secreted by bacterial cells or expressed on their surfaces may cause efficient anti-antimicrobial responses, meaning that bacteria could potentially thrive in the presence of the peptides. This discovery may give scientists a better understanding of bacterial resistance and help them choose the right approach when developing the peptides for medical use.

Dr. Max Ryadnov, who leads NPL's  scientific research in Biotechnology, said: “It is widely known that these antimicrobial peptides are very efficient at destroying bacteria, but previous measurement techniques only let us see to a detail of five nanometres. The unique combination of technologies used in this research allowed us to see the process at larger length scales and in finer detail. The implications of these research efforts could be considerable - potentially paving the way for an alternative to the current, increasingly inefficient, antibiotic treatments, but also helping us understand the potential vulnerabilities of therapeutics based on these peptides.”

The research was led by NPL and featured scientists from the London Centre for Nanotechnology, UCL, University of Edinburgh, University of Bristol, University of Oxford, Freie Universität Berlin and IBM.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Blend Synthetic Air to Measure Climate Change
Scientists at the NPL have produced a synthetic air reference standard which can be used to accurately measure levels of carbon dioxide and methane in the atmosphere.
Wednesday, February 26, 2014
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!